![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Scheen André J
Publisher: Informa Healthcare
ISSN: 1742-5255
Source: Expert Opinion on Drug Metabolism and Toxicology, Vol.10, Iss.6, 2014-06, pp. : 839-857
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. :